Astrotech Corporation (Nasdaq: ASTC) has reported its financial results for the third quarter of fiscal year 2025, ending March 31, 2025. The company announced a significant increase in revenue, reaching $534 thousand compared to $50 thousand in the same period of fiscal year 2024. This revenue comprises shipments of the TRACER 1000™, a government grant, and recurring consumable sales and maintenance services. In terms of business developments, Astrotech's 1st Detect subsidiary secured a research and development contract with the Department of Homeland Security to enhance the TRACER 1000 for next-generation explosives trace detection. Additionally, 1st Detect received a $429 thousand purchase order for its TRACER 1000™ ETDs from Intuitive Research and Technology Corporation, a TSA contractor, which was fulfilled and recognized as revenue in the reported quarter. The company also announced the creation of a new wholly-owned subsidiary, EN-SCAN, Inc., aimed at manufacturing and selling instruments for environmental testing applications using proprietary technology. Furthermore, the TRACER 1000 NTD has been configured to accurately and swiftly screen for synthetic opiates and novel psychoactive substances, addressing the global drug crisis. Astrotech's consolidated balance sheet remains strong, with $20.9 million in cash, cash equivalents, and liquid investments to support ongoing R&D projects and the transition to a selling and marketing-focused company. This is a decrease from the $31.9 million reported on June 30, 2024. The company is optimistic about its momentum into fiscal year 2026 with its new product lines, including the TRACER NTD, Pro-Control, and EN-SCAN.